Literature DB >> 34267813

Mammospheres of letrozole-resistant breast cancer cells enhance breast cancer aggressiveness.

Jankiben R Patel1, Karen M Gallegos1, Rashidra R Walker1, A Michael Davidson1, Ian Davenport2, Syreeta L Tilghman1.   

Abstract

Aromatase inhibitors (AIs), such as letrozole, are considered as first-line treatment for estrogen receptor-positive breast cancer in postmenopausal women. Despite the successful use of letrozole, resistance to therapy, tumor relapse and metastasis remain principal causes of patient mortality. Although there is no therapy currently available for AI-resistant breast cancer, previous reports have demonstrated that AI resistance is associated with hormone independence, increased growth factor signaling, enhanced cellular motility and epithelial to mesenchymal transition (EMT). This suggests a convergence of EMT and cancer stem cells (CSCs) in endocrine resistance. The present study evaluated the contribution of mammospheres in letrozole-resistant breast cancer by characterizing mammospheres and their potential impact on cellular motility. Ovariectomized immunocompromised female mice were inoculated in the mammary fat pad with either letrozole-resistant MCF-7 cells (LTLT-Ca) or letrozole-sensitive MCF-7 cells (AC-1). Subsequently, intratumoral CSC marker expression was assessed by immunohistochemistry. The results indicated that LTLT-Ca tumors were CD44+/CD24+, while AC-1 tumors presented low CD44/CD24 expression. Since mammosphere formation depends on CSCs, both cell lines were cultured either adherently (2D) or as mammospheres (3D) to assess the CD44/CD24 protein expression profile. When 3D culturing both cell lines, higher expression levels of CD44 and CD24 were observed when compared with their adherent counterparts, with the most robust change observed in the LTLT-Ca cell line. To quantitate the breast cancer stem cell activity, mammosphere formation assays were performed, and the LTLT-Ca cells formed mammospheres at a 3.4-fold higher index compared with AC-1 cells. Additionally, targeted gene expression arrays were conducted to compare the LTLT-Ca 3D and 2D cells, revealing that LTLT-Ca 3D cells displayed decreased expression levels of genes involved in cell adhesion and tumor suppression (e. g., E-cadherin, caveolin 1 and β-catenin). To validate this finding, wound healing assays were performed, and LTLT-Ca mammospheres exhibited a 70% wound closure, whereas AC-1 mammospheres exhibited a 39% wound closure. Collectively, the present findings demonstrated a strong association between AI-resistant mammospheres and an increased propensity for migration, which may be indicative of a poor prognosis.
Copyright © 2021, Spandidos Publications.

Entities:  

Keywords:  CD24; CD44; aromatase inhibitors; breast cancer; cancer stem cells; epithelial to mesenchymal transition; letrozole resistance; mammospheres

Year:  2021        PMID: 34267813      PMCID: PMC8258623          DOI: 10.3892/ol.2021.12881

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  43 in total

1.  Proteomic signatures of acquired letrozole resistance in breast cancer: suppressed estrogen signaling and increased cell motility and invasiveness.

Authors:  Syreeta L Tilghman; Ian Townley; Qiu Zhong; Patrick P Carriere; Jin Zou; Shawn D Llopis; Lynez C Preyan; Christopher C Williams; Elena Skripnikova; Melyssa R Bratton; Qiang Zhang; Guangdi Wang
Journal:  Mol Cell Proteomics       Date:  2013-05-23       Impact factor: 5.911

2.  Efficacy and mechanism of action of Proellex, an antiprogestin in aromatase overexpressing and Letrozole resistant T47D breast cancer cells.

Authors:  Akash Gupta; Rajeshwari Mehta; Fatouma Alimirah; Xinjian Peng; Genoveva Murillo; Ronald Wiehle; Rajendra G Mehta
Journal:  J Steroid Biochem Mol Biol       Date:  2012-08-23       Impact factor: 4.292

3.  Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype.

Authors:  Sara Ricardo; André Filipe Vieira; Renê Gerhard; Dina Leitão; Regina Pinto; Jorge F Cameselle-Teijeiro; Fernanda Milanezi; Fernando Schmitt; Joana Paredes
Journal:  J Clin Pathol       Date:  2011-06-16       Impact factor: 3.411

Review 4.  Adaptive changes results in activation of alternate signaling pathways and resistance to aromatase inhibitor resistance.

Authors:  Gauri Sabnis; Angela Brodie
Journal:  Mol Cell Endocrinol       Date:  2010-09-16       Impact factor: 4.102

5.  Caveolin-1 and mitochondrial SOD2 (MnSOD) function as tumor suppressors in the stromal microenvironment: a new genetically tractable model for human cancer associated fibroblasts.

Authors:  Casey Trimmer; Federica Sotgia; Diana Whitaker-Menezes; Renee M Balliet; Gregory Eaton; Ubaldo E Martinez-Outschoorn; Stephanos Pavlides; Anthony Howell; Renato V Iozzo; Richard G Pestell; Philipp E Scherer; Franco Capozza; Michael P Lisanti
Journal:  Cancer Biol Ther       Date:  2011-02-15       Impact factor: 4.742

6.  Clinical and functional significance of loss of caveolin-1 expression in breast cancer-associated fibroblasts.

Authors:  Samantha A Simpkins; Andrew M Hanby; Deborah L Holliday; Valerie Speirs
Journal:  J Pathol       Date:  2012-05-23       Impact factor: 7.996

7.  The epithelial-mesenchymal transition generates cells with properties of stem cells.

Authors:  Sendurai A Mani; Wenjun Guo; Mai-Jing Liao; Elinor Ng Eaton; Ayyakkannu Ayyanan; Alicia Y Zhou; Mary Brooks; Ferenc Reinhard; Cheng Cheng Zhang; Michail Shipitsin; Lauren L Campbell; Kornelia Polyak; Cathrin Brisken; Jing Yang; Robert A Weinberg
Journal:  Cell       Date:  2008-05-16       Impact factor: 41.582

8.  STEAP1 Inhibits Breast Cancer Metastasis and Is Associated With Epithelial-Mesenchymal Transition Procession.

Authors:  Jie Xie; Yan Yang; Jiali Sun; Zhi Jiao; Haozheng Zhang; Jie Chen
Journal:  Clin Breast Cancer       Date:  2018-08-30       Impact factor: 3.225

9.  Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis.

Authors:  Wenzhe Li; Huailei Ma; Jin Zhang; Ling Zhu; Chen Wang; Yanlian Yang
Journal:  Sci Rep       Date:  2017-10-23       Impact factor: 4.379

10.  Glyceollin I Reverses Epithelial to Mesenchymal Transition in Letrozole Resistant Breast Cancer through ZEB1.

Authors:  Patrick P Carriere; Shawn D Llopis; Anna C Naiki; Gina Nguyen; Tina Phan; Mary M Nguyen; Lynez C Preyan; Letitia Yearby; Jamal Pratt; Hope Burks; Ian R Davenport; Thu A Nguyen; KiTani Parker-Lemieux; Florastina Payton-Stewart; Christopher C Williams; Stephen M Boué; Matthew E Burow; Bridgette Collins-Burow; Aaron Hilliard; A Michael Davidson; Syreeta L Tilghman
Journal:  Int J Environ Res Public Health       Date:  2015-12-22       Impact factor: 3.390

View more
  2 in total

1.  A Novel Allosteric Inhibitor Targets PLK1 in Triple Negative Breast Cancer Cells.

Authors:  Jankiben R Patel; Prasad Thangavelu; Renee M Terrell; Bridg'ette Israel; Arindam Basu Sarkar; A Michael Davidson; Kun Zhang; Rahul Khupse; Syreeta L Tilghman
Journal:  Biomolecules       Date:  2022-03-31

2.  Glyceollins Trigger Anti-Proliferative Effects in Hormone-Dependent Aromatase-Inhibitor-Resistant Breast Cancer Cells through the Induction of Apoptosis.

Authors:  Rashidra R Walker; Jankiben R Patel; Akash Gupta; A Michael Davidson; Christopher C Williams; Florastina Payton-Stewart; Stephen M Boué; Matthew E Burow; Rahul Khupse; Syreeta L Tilghman
Journal:  Int J Mol Sci       Date:  2022-03-07       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.